<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
    "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="OriginalFile" content="9782 Naloxone prescription dispensing administration by third party limitation of liability.doc" />
<meta name="generator" content="Adobe RoboHelp 2019" />
<title>40:978.2</title>
<link rel="stylesheet" href="../statute3.css" type="text/css" />
<script type="text/javascript" language="JavaScript">
//<![CDATA[
function reDo() {
  if (innerWidth != origWidth || innerHeight != origHeight)
     location.reload();
}
if ((parseInt(navigator.appVersion) == 4) && (navigator.appName == "Netscape")) {
        origWidth = innerWidth;
        origHeight = innerHeight;
        onresize = reDo;
}
onerror = null; 
//]]>
</script>
<style type="text/css">
/*<![CDATA[*/
<!--
div.WebHelpPopupMenu { position:absolute;
left:0px;
top:0px;
z-index:4;
visibility:hidden; }
-->
/*]]>*/
</style>

<script type="text/javascript" language="javascript1.2" src="../whmsg.js" charset="utf-8">
</script>
<script type="text/javascript" language="javascript" src="../whver.js" charset="utf-8">
</script>
<script type="text/javascript" language="javascript1.2" src="../whutils.js" charset="utf-8">
</script>
<script type="text/javascript" language="javascript1.2" src="../whproxy.js" charset="utf-8">
</script>
<script type="text/javascript" language="javascript1.2" src="../whlang.js" charset="utf-8">
</script>
<script type="text/javascript" language="javascript1.2" src="../whtopic.js" charset="utf-8">
</script>
</head>
<body style="word-wrap: break-word; text-justify-trim: punctuation;">
<script type="text/javascript" language="javascript1.2">
//<![CDATA[
<!--
if (window.gbWhTopic)
{
        var strUrl = decodeURI(document.location.href);
        var bc = 0;
        var n = strUrl.toLowerCase().indexOf("bc-");
        if(n != -1)
        {
                document.location.replace(strUrl.substring(0, n));
                bc = strUrl.substring(n+3);
        }

        if (window.addTocInfo)
        {
        addTocInfo("Caddo Parish School Board\nStatutes\nTitle 40\n40:978.2");

        }
        if (window.writeBtnStyle)
                writeBtnStyle();

        if (window.writeIntopicBar)
                writeIntopicBar(0);

        
        
}
else
        if (window.gbIE4)
                document.location.reload();

onLoadHandler = function()
{
  if (window.setRelStartPage)
        {
        setTimeout("setRelStartPage('../CaddoCAPS.htm');", 1)

    setTimeout("UpdateBreadCrumbsMarker();", 1);
        }
}

if (window.addEventListener){  
        window.addEventListener('load', onLoadHandler, false);   
} else if (window.attachEvent){  
        window.attachEvent('onload', onLoadHandler);  
}

function onSetStartPage()
{
  autoSync(0);
  sendSyncInfo();
  sendAveInfoOut();
}
//-->
//]]>
</script><script type="text/javascript" src="../ehlpdhtm.js" language="JavaScript1.2">
</script>
<p class="PdfParaStyle01"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">Title 40. Public Health and Safety</font></span></p>
<p class="PdfParaStyle01"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">Chapter 4. Food and Drugs</font></span></p>
<p class="PdfParaStyle01"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">Part X. Uniform Controlled Dangerous Substances Law</font></span></p>
<span style="font-size: 10.0pt; font-family: Arial, sans-serif;"><font size="2" style="font-size:10pt;"><br style="clear: all;" /></font></span>
<p style="margin-bottom: 0in; line-height: normal; text-autospace: none;">&#160;</p>
<p class="PdfParaStyle04"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #252525;"><font size="2" color="#252525" style="font-size:10.000000pt;">40:978.2&#160;&#160;&#160;Naloxone; prescription; dispensing; administration by third party; limitation of liability</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">A. A licensed medical practitioner may, directly or by standing order, prescribe or dispense the drug naloxone or another opioid antagonist without having examined the individual to whom it may be administered if both of the following conditions are met:</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">(1) The licensed medical practitioner provides the individual receiving and administering the naloxone or other opioid antagonist all training required by the department for the safe and proper administration of naloxone or another opioid antagonist to individuals who are undergoing or who are believed to be undergoing an opioid-related drug overdose. The training, at a minimum, shall address all of the following:&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">(a) Techniques on how to recognize signs of an opioid-related drug overdose.&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">(b) Standards and procedures for the storage and administration of naloxone or another opioid antagonist.&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">(c) Emergency follow-up procedures including the requirement to summon emergency services either immediately before or immediately after administering the naloxone or other opioid antagonist to an individual apparently experiencing an opioid-related drug overdose.&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">(2) The naloxone or other opioid antagonist is prescribed or dispensed in such a manner that it shall be administered through a device approved for this purpose by the United States Food and Drug Administration.&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">B. A licensed medical practitioner who, in good faith, prescribes or dispenses naloxone or another opioid antagonist pursuant to Subsection A of this Section shall not, as a result of any act or omission, be subject to civil liability, criminal prosecution, or disciplinary or other adverse action under any professional licensing statute.&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">C. (1)(a) A licensed pharmacist shall dispense naloxone or another opioid antagonist prescribed, directly or by standing order, by a licensed medical practitioner pursuant to this Section.&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">(b) A licensed pharmacist may dispense naloxone or another opioid antagonist pursuant to a nonpatient-specific standing order as provided for in rules promulgated by the Louisiana Board of Pharmacy.&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">(2) A licensed pharmacist who, in good faith, dispenses naloxone or another opioid antagonist pursuant to this Subsection shall not, as a result of any act or omission, be subject to civil liability, criminal prosecution, or disciplinary or other adverse action under any professional licensing statute.&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">D. Notwithstanding any other provision of law or regulation, a person or organization acting pursuant to a standing order issued by a healthcare professional who is authorized to prescribe naloxone or another opioid antagonist may store naloxone or another opioid antagonist and may dispense naloxone or another opioid antagonist if such activities are performed without charge or compensation.&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">E. Notwithstanding any other provision of law or regulation, any person may lawfully possess naloxone or another opioid antagonist.&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">F. A person acting in good faith who, pursuant to the provisions of this Section, receives and administers naloxone or another opioid antagonist to a person reasonably believed to be undergoing an opioid-related drug overdose shall be immune from criminal and civil liability for the administration, unless personal injury results from the gross negligence or willful or wanton misconduct in the administration of the drug.&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">G. The department shall develop and promulgate a set of best practices for use by a licensed medical practitioner pursuant to this Section including but not limited to the training necessary to safely and properly administer naloxone or another opioid antagonist to individuals who are undergoing or who are believed to be undergoing an opioid-related drug overdose, the standards and procedures for the storage and administration of naloxone or another opioid antagonist, and emergency follow-up procedures.&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">H. For the purposes of this Section the following definitions apply:&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">(1) “Department” means the Louisiana Department of Health.&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">(2) “Licensed medical practitioner” means a physician or other healthcare practitioner licensed, certified, registered, or otherwise authorized to perform specified healthcare services consistent with state law.&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">(3) “Opioid-related drug overdose” means a condition including extreme physical illness, decreased level of consciousness, respiratory depression, coma, or the ceasing of respiratory or circulatory function resulting from the consumption or use of an opioid, or another substance with which an opioid was combined.&#160;</font></span></p>
<p style="margin-bottom: 0in; text-align: justify; text-justify: inter-ideograph; line-height: normal; text-autospace: none;">&#160;</p>
<p class="PdfParaStyle10"><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">Added by</font></span> <span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000; text-underline: none; text-decoration: none;"><font size="2" color="black" style="font-size:10.000000pt;">Acts 2015, No. 192, § 1</font></span><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">. Amended by</font></span> <span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000; text-underline: none; text-decoration: none;"><font size="2" color="black" style="font-size:10.000000pt;">Acts 2016, No. 370, § 1, eff. June 5, 2016</font></span><span style="font-size: 10.0pt; font-family: Arial, sans-serif; color: #000000;"><font size="2" color="black" style="font-size:10.000000pt;">.</font></span></p>
<script type="text/javascript" language="javascript1.2">
//<![CDATA[
<!--
if (window.writeIntopicBar)
        writeIntopicBar(0);


highlightSearch();
//-->
//]]>
</script>
</body>
</html>
